NCT00819286

Brief Summary

The goal of this study is to evaluate sternal osteosynthesis, chest wall pain and return to normal activity in open heart surgery patients who had their breast bone closed either with wires or plates.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2008

Typical duration for not_applicable

Geographic Reach
2 countries

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 8, 2009

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
4 months until next milestone

Results Posted

Study results publicly available

March 15, 2012

Completed
Last Updated

February 13, 2018

Status Verified

January 1, 2018

Enrollment Period

2.2 years

First QC Date

January 6, 2009

Results QC Date

December 27, 2011

Last Update Submit

January 16, 2018

Conditions

Keywords

open heart surgery

Outcome Measures

Primary Outcomes (2)

  • CT Scan Evaluation of Sternal Bone Healing

    Quantitative evaluation of sternal bone healing at 5 anatomical locations along the sternum using a 6 point quantitative scale (0= no healing and 5= complete healing)

    3 and 6 Months

  • Activity Based Total Visual Analog Pain Score

    Postoperative VAS pain scores (scale of 0-10 for each; 0= no pain, 10= worst pain imaginable) were evaluated as a function of resting, coughing, sneezing and general movement. The sum of these was used to derive an "Activity Based Total Visual Analog Pain Score", (scale of 0-40; 0= no pain, 40= worst pain imaginable). For this primary endpoint analysis, the total score at 6 months was evaluated.

    6 months

Study Arms (2)

wire (control)

ACTIVE COMPARATOR

patients will have their sternum closed using wire (stainless steel surgical wire).

Device: wire (control)

SternaLock Rigid Fixation Plates

EXPERIMENTAL

patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates.

Device: SternaLock Rigid Fixation Plates

Interventions

patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates

SternaLock Rigid Fixation Plates

patients will have their sternum closed using wire (stainless steel surgical wire).

wire (control)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing median sternotomy;
  • Patients eighteen (18) years of age or older;
  • Patients presenting two or more risk factors such as diabetes mellitus, Chronic Obstructive Pulmonary Disease, obesity (BMI \> 30), osteoporosis, Renal failure, Chronic steroid use, Immunosuppression, Redo sternotomy, Neurologic dysfunction severely affecting ambulation,
  • Off mid-line sternotomy
  • bilateral IMA use
  • Long cardio-pulmonary bypass runs
  • Transverse fractures of the sternum

You may not qualify if:

  • Patients with a non-standard sternotomy;
  • Patients with an off-midline sternotomy that reduced the bony margin to \<2mm
  • Patients under eighteen (18) years of age;
  • Patients that are pregnant or currently lactating;
  • Patients presenting intra-operative conditions that would require the use of rigid fixation and/or additional post-sternotomy mechanical support beyond wire cerclage due to surgical evaluation,
  • Patients defined within the New York Heart Association (NYHA) or Canadian Cardiovascular Society (CCS) functional Class IV for congestive heart failure,
  • Patients presenting emergent/salvage cardiac acuity as defined per the Society of Thoracic Surgeons (STS) guidelines: i.e., patients undergoing cardiopulmonary resuscitation en route to the operating room or prior to induction of anesthesia;
  • Patients undergoing post-operative revision procedures that treat the original sternotomy in such a way as to affect outcome (antibiotic irrigation, debridement or other treatment to the osteotomy);
  • Patients unwilling or unable to return for follow-up;
  • Lacking the ability to follow instructions;
  • Intraoperative death.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

St. Joseph's Heart and Lung Institute

Phoenix, Arizona, 85013, United States

Location

University of California Davis Medical Center

Sacramento, California, 95817, United States

Location

University of Chicago

Chicago, Illinois, 60637, United States

Location

Baptist Memorial Hospital

Memphis, Tennessee, 38120, United States

Location

Scott & White Memorial Hospital

Temple, Texas, 76508, United States

Location

Leipzig Heart Center

Leipzig, Germany

Location

MeSH Terms

Conditions

PainMediastinitis

Interventions

Bone Wires

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMediastinal DiseasesThoracic DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Internal FixatorsProstheses and ImplantsEquipment and SuppliesOrthopedic Fixation DevicesOrthopedic EquipmentSurgical EquipmentSurgical Fixation Devices

Results Point of Contact

Title
Brian Hatcher
Organization
Biomet Microfixation

Study Officials

  • Jai Raman, MD

    University of Chicago

    STUDY CHAIR
  • Michael Wong, MD

    University of California Davis Medical Center, Sacramento, CA

    PRINCIPAL INVESTIGATOR
  • Brian DeGuzmann, MD

    St. Joseph's Medical Center, Phoenix, AZ

    PRINCIPAL INVESTIGATOR
  • Sven Lehmann, MD

    Leipzig Heart Center, Leipzig, Germany

    PRINCIPAL INVESTIGATOR
  • Kenton Zehr, MD

    Scott & White Memorial Hospital, Temple, TX

    PRINCIPAL INVESTIGATOR
  • H Edward Garrett, Jr, MD

    Baptist Memorial Hospital, Memphis, TN

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participant blinded to treatment assignment until completion of study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2009

First Posted

January 8, 2009

Study Start

November 1, 2008

Primary Completion

January 1, 2011

Study Completion

December 1, 2011

Last Updated

February 13, 2018

Results First Posted

March 15, 2012

Record last verified: 2018-01

Locations